Literature DB >> 19521433

The profile of strabismus in stroke survivors.

F Rowe1.   

Abstract

AIM: To evaluate the profile of strabismus that occurs in stroke survivors and determine the relationship between site of stroke and symptom of diplopia.
METHODS: Prospective multi-centre cohort trial involving 16 recruiting centres (Vision In Stroke (VIS) Group). Standardised referral and investigation protocol used by local investigators. Each patient underwent assessment of ocular alignment, motility, and binocular vision. Results were evaluated with non-parametric statistical tests.
RESULTS: In all, 512 patients were recruited with a mean age of 69 years: SD 15 over a 2-year period (59% male patients, 41% female patients). Median duration from onset to vision assessment was 19 days (range 0-1140 days). About 19% of the patients had strabismus detected on orthoptic investigation after the onset of stroke. Of these strabismic patients 12.5% had strabismus that pre-existed the onset of stroke (that could be determined from case history). A total of 70% had strabismus associated with ocular motility abnormalities and 30% were in isolation. About 24% were associated with brain stem, cerebellar, thalamus or basal ganglia strokes, and 73% with cortical strokes. Around 36% complained of diplopia and the remainder had no symptoms related to their strabismus.
CONCLUSIONS: Strabismus was found to occur in 16.5% of patients after their stroke. Strabismus with diplopia was always associated with other ocular motility abnormalities, whereas strabismus without associated ocular motility abnormalities did not result in the symptom of diplopia.

Entities:  

Mesh:

Year:  2009        PMID: 19521433     DOI: 10.1038/eye.2009.138

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

Review 1.  Update on the Clinical Approach to Spatial Neglect.

Authors:  A M Barrett; K E Houston
Journal:  Curr Neurol Neurosci Rep       Date:  2019-04-04       Impact factor: 5.081

2.  Restoration of Vision After Brain Injury Using Magnet Glasses.

Authors:  Kevin E Houston; Eleftherios I Paschalis; Danielle C Angueira; P Matthew Bronstad; Anna M Barrett; Mary Alexis Iaccarino
Journal:  Am J Phys Med Rehabil       Date:  2017-04       Impact factor: 2.159

3.  Prevalence of ocular motor cranial nerve palsy and associations following stroke.

Authors:  F Rowe
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

4.  Isolated schwannoma involving extraocular muscles.

Authors:  Fatma Yulek; Joseph L Demer
Journal:  J AAPOS       Date:  2016-07-14       Impact factor: 1.220

Review 5.  Interventions for eye movement disorders due to acquired brain injury.

Authors:  Fiona J Rowe; Kerry Hanna; Jennifer R Evans; Carmel P Noonan; Marta Garcia-Finana; Caroline S Dodridge; Claire Howard; Kathryn A Jarvis; Sonia L MacDiarmid; Tallat Maan; Lorraine North; Helen Rodgers
Journal:  Cochrane Database Syst Rev       Date:  2018-03-05

Review 6.  Eyes and stroke: the visual aspects of cerebrovascular disease.

Authors:  John H Pula; Carlen A Yuen
Journal:  Stroke Vasc Neurol       Date:  2017-07-06

7.  Profile of Gaze Dysfunction following Cerebrovascular Accident.

Authors:  Fiona J Rowe; David Wright; Darren Brand; Carole Jackson; Shirley Harrison; Tallat Maan; Claire Scott; Linda Vogwell; Sarah Peel; Nicola Akerman; Caroline Dodridge; Claire Howard; Tracey Shipman; Una Sperring; Sonia Macdiarmid; Cicely Freeman
Journal:  ISRN Ophthalmol       Date:  2013-10-10

8.  Neurological signs in 23 dogs with suspected rostral cerebellar ischaemic stroke.

Authors:  Barbara Thomsen; Laurent Garosi; Geoff Skerritt; Clare Rusbridge; Tim Sparrow; Mette Berendt; Hanne Gredal
Journal:  Acta Vet Scand       Date:  2016-06-07       Impact factor: 1.695

9.  Visual effects and rehabilitation after stroke.

Authors:  Fiona Rowe
Journal:  Community Eye Health       Date:  2016

10.  Accuracy and Feasibility of an Android-Based Digital Assessment Tool for Post Stroke Visual Disorders-The StrokeVision App.

Authors:  Terence J Quinn; Iain Livingstone; Alexander Weir; Robert Shaw; Andrew Breckenridge; Christine McAlpine; Claire M Tarbert
Journal:  Front Neurol       Date:  2018-03-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.